UK consortium to help accelerate adoption of low carbon medicinal manufacturing
UK consortium to help accelerate the adoption of low carbon medicines manufacturing
Credit: bidaala-studio/Shutterstock
A new UK-based consortium, led by Exactmer, with strategic support from GSK, has been awarded over £7 million in funding from Innovate UK in partnership with the Department of Health and Social Care (DHSC), to advance the production of high purity bio-based solvents for medicines manufacturing. The 36-month project aims to bolster the UK’s leadership in sustainable pharmaceutical manufacturing and accelerate the scale-up of bio-based solvents for low-carbon medicine manufacturing.
Register for FREE to keep reading
Join 12,000+ scientists, engineers, and IT professionals driving innovation through informatics, HPC, and simulation with:
- Insights into HPC, AI, lab informatics & data
- Curated content for life sciences, engineering & academia
- Access to Breakthroughs: real-world computing success
- Free reports & panels, including the Lab Informatics Guide
- White Papers & software updates for smarter research
Sign up now
Already a member? Log in here
Your data is protected under our privacy policy.
